Latest EU medtech proposals take a different view on fees
This article was originally published in SRA
A detailed analysis of the Council of the EU’s recently published amendments to the proposed Medical Device Regulation reveals that the council’s views on fees which manufacturers have to pay to meet the new requirements diverge significantly from those of the European Commission1,2. The council is also wanting EU “expert panels” and “expert laboratories” to take over the role of existing EU reference laboratories but with slightly different responsibilities.
You may also be interested in...
While the UK is moving forward quickly to provide COVID-19 antibody self-testing, the Belgian government considers the tests not sufficiently accurate to be used in the pandemic.
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
The UK is taking measures to increase its ventilator stock from 8,000 to some 30,000, but it will take time to make them available. Many are asking whether the government really rejected EU help, which could have brought relief sooner, because of Brexit.